This conversion strategy was applied either to human fibroblasts with induced expression of a mutant APP or derived from sporadic AD patient fibroblasts with an APOE ε3/4 allele that is an AD risk factor (Kim et al., 2017). Here, APP is linked to Alzheimer disease.